Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With 3 Cycles Pulses of High-dose Dexamethasone (HD-DXM)

NCT02914054 is registered in ClinicalTrials.gov with Isfahan University of Medical Sciences as lead sponsor.

NCT NCT02914054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With 3 Cycles Pulses of High-dose Dexamethasone (HD-DXM)
Lead sponsor
Isfahan University of Medical Sciences
Phase
Phase 2/3
Overall status
Completed
Start date
October 1, 2016
Completion date
September 15, 2017
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

croticosteroid therapy, itp